IP Library Assignment 032703/0001
Patent Assignment
Reel/Frame 032703/0001

Assignment of Assignor's Interest

Recorded: 2014-04-17 Pages: 4
Assignors
CARR, FRANCIS J.
Executed: 2014-03-12
JONES, TIMOTHY D.
Executed: 2014-03-12
KEEN, SIMON WILLIAM
Executed: 2014-03-12
Assignee
VASCULAR PHARMACEUTICALS, INC.
830 MARY ELLEN JONES BUILDING, 116 MANNING DRIVE, CHAPEL HILL, NORTH CAROLINA, 27599
Covered Property (1)
Monoclonal Antibodies for Enhancing or Inhibiting Insulin-Like Growth Factor 1 (Igf-1)
Patent: 9,073,996 →
Application: 14/015,457 →
Publication: US 2014/0072568
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Confirmatory License Feb 26, 2014
From: THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 032334/0740 →
Assignment of Assignor's Interest Apr 17, 2014
From: CLEMMONS, DAVID; MAILE, LAURA
To: NORTH CAROLINA AT CHAPEL HILL, THE UNIVERSITY OF
Reel/Frame 032702/0895 →
Assignment of Assignor's Interest Apr 17, 2014
From: NASO, MICHAEL
To: VASCULAR PHARMACEUTICALS, INC.
Reel/Frame 032703/0042 →
Assignment of Assignor's Interest May 23, 2014
From: VASCULAR PHARMACEUTICALS, INC.
To: THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
Reel/Frame 032956/0359 →